![David B. Krasne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David B. Krasne
Directeur Général chez
Sentire Medical Systems, Inc.
Profil
David B. Krasne is the founder of Sentire Medical Systems, Inc., founded in 2012, where the title held is Chief Executive Officer.
Mr. Krasne is the founder of RedNest Partners, LLC, founded in 2016, holding the title of Partner.
Current jobs include Director at Tecmotiv USA, Inc. since 2019 and Chief Financial Officer at Nanocan Therapeutics Corp.
since 2022.
Former jobs include CEO & Director at American Medical Forensic Specialists, Inc. from 2010 to 2016, Senior Associate at Riverside Partners LLC (New York) from 2006 to 2008, and Principal at Merrill Lynch Global Private Equity, Inc. from 2000 to 2004.
Education includes an MBA from the University of California, Los Angeles, and undergraduate studies at The Pennsylvania State University.
Postes actifs de David B. Krasne
| Sociétés | Poste | Début |
|---|---|---|
Sentire Medical Systems, Inc.
 Sentire Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops revolutionary monitoring system | Directeur Général | 01/01/2012 |
RedNest Partners, LLC
 RedNest Partners, LLC Investment ManagersFinance RedNest Partners invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for growth stage capital requirements. | Fondateur | 01/10/2016 |
Nanocan Therapeutics Corp.
 Nanocan Therapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a bio technology company | Directeur Financier/CFO | 01/01/2022 |
Tecmotiv USA, Inc.
 Tecmotiv USA, Inc. Motor VehiclesConsumer Durables Provides maintenance, repair, overhaul and upgrade services and related components for military vehicle platforms | Directeur/Membre du Conseil | 01/07/2019 |
Anciens postes connus de David B. Krasne
| Sociétés | Poste | Fin |
|---|---|---|
American Medical Forensic Specialists, Inc.
 American Medical Forensic Specialists, Inc. Hospital/Nursing ManagementHealth Services Provides medical services | Directeur Général | 31/12/2016 |
Riverside Partners LLC (New York)
 Riverside Partners LLC (New York) Investment ManagersFinance Riverside Partners invests in small and middle market companies located across the globe with an EBITDA of USD 10 million - 35 million. The firm focuses on companies operating in the fields of business, consumer, education & training, franchisors, healthcare, software & IT, specialty manufacturing, and thematic investing. It provides financing in growth stage capital transactions and provides non-control options. | Analyste en capital-investissement | 31/07/2008 |
Merrill Lynch Global Private Equity, Inc.
 Merrill Lynch Global Private Equity, Inc. Investment ManagersFinance MLGP's objective is to generate long-term capital gains, with a primary focus on control-oriented investments in equity, equity-related and similar securities with equity-like returns. Investments typically range in size from $250 million to $750 million, with the flexibility to commit to larger or smaller investments. MLGP makes investments globally, with a primary emphasis on the world's largest economies, including the US, Europe, Japan, China, India, Latin America and Australia, taking a multi-sector approach to identifying attractive investment opportunities. They target investments in high quality, established companies that are recognized brands with industry or regional leadership, defensible market positions, strong cash flow characteristics and seasoned management. They combine comprehensive regional and industry-based in-depth analyses with global approval and management processes. Their approach combines an intensive, bottom-up evaluation process including gaining a detailed understanding of a potential portfolio company's value drivers, management capabilities, cost structure, cash flow characteristics, market position and competitive advantages with a top-down analysis of the attractiveness, growth potential and underlying economics of the industry, competitive environment and exit alternatives. When making an investment, MLGPE takes a control-oriented approach and seeks to structure transactions to ensure the ability to influence critical decisions for a portfolio company, particularly as it relates to specific value-added initiatives. A key element of their transaction negotiation with partners and management centers on contractual rights and board representation that facilitate input into key decisions such as management changes, expansion plans, acquisitions, budgets, debt and equity financings and new initiatives. MLGP implements value creation initiatives such as organic growth alternatives, acquisitions and other strategic initiatives, business rationalization and operational improvements and capital structure improvements in partnership with portfolio company management. They are actively involved in significant portfolio company decisions, including those relating to potential acquisitions, expansion plans, debt and equity financings, changes in senior management and new business initiatives. | Corporate Officer/Principal | 31/12/2004 |
Merrill Lynch Global Private Equity, Inc.
Merrill Lynch Global Private Equity, Inc. Investment ManagersFinance MLGP's objective is to generate long-term capital gains, with a primary focus on control-oriented investments in equity, equity-related and similar securities with equity-like returns. Investments typically range in size from $250 million to $750 million, with the flexibility to commit to larger or smaller investments. MLGP makes investments globally, with a primary emphasis on the world's largest economies, including the US, Europe, Japan, China, India, Latin America and Australia, taking a multi-sector approach to identifying attractive investment opportunities. They target investments in high quality, established companies that are recognized brands with industry or regional leadership, defensible market positions, strong cash flow characteristics and seasoned management. They combine comprehensive regional and industry-based in-depth analyses with global approval and management processes. Their approach combines an intensive, bottom-up evaluation process including gaining a detailed understanding of a potential portfolio company's value drivers, management capabilities, cost structure, cash flow characteristics, market position and competitive advantages with a top-down analysis of the attractiveness, growth potential and underlying economics of the industry, competitive environment and exit alternatives. When making an investment, MLGPE takes a control-oriented approach and seeks to structure transactions to ensure the ability to influence critical decisions for a portfolio company, particularly as it relates to specific value-added initiatives. A key element of their transaction negotiation with partners and management centers on contractual rights and board representation that facilitate input into key decisions such as management changes, expansion plans, acquisitions, budgets, debt and equity financings and new initiatives. MLGP implements value creation initiatives such as organic growth alternatives, acquisitions and other strategic initiatives, business rationalization and operational improvements and capital structure improvements in partnership with portfolio company management. They are actively involved in significant portfolio company decisions, including those relating to potential acquisitions, expansion plans, debt and equity financings, changes in senior management and new business initiatives. | Corporate Officer/Principal | - |
Formation de David B. Krasne
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Riverside Partners LLC (New York)
Riverside Partners LLC (New York) Investment ManagersFinance Riverside Partners invests in small and middle market companies located across the globe with an EBITDA of USD 10 million - 35 million. The firm focuses on companies operating in the fields of business, consumer, education & training, franchisors, healthcare, software & IT, specialty manufacturing, and thematic investing. It provides financing in growth stage capital transactions and provides non-control options. | Finance |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merrill Lynch Global Private Equity, Inc.
Merrill Lynch Global Private Equity, Inc. Investment ManagersFinance MLGP's objective is to generate long-term capital gains, with a primary focus on control-oriented investments in equity, equity-related and similar securities with equity-like returns. Investments typically range in size from $250 million to $750 million, with the flexibility to commit to larger or smaller investments. MLGP makes investments globally, with a primary emphasis on the world's largest economies, including the US, Europe, Japan, China, India, Latin America and Australia, taking a multi-sector approach to identifying attractive investment opportunities. They target investments in high quality, established companies that are recognized brands with industry or regional leadership, defensible market positions, strong cash flow characteristics and seasoned management. They combine comprehensive regional and industry-based in-depth analyses with global approval and management processes. Their approach combines an intensive, bottom-up evaluation process including gaining a detailed understanding of a potential portfolio company's value drivers, management capabilities, cost structure, cash flow characteristics, market position and competitive advantages with a top-down analysis of the attractiveness, growth potential and underlying economics of the industry, competitive environment and exit alternatives. When making an investment, MLGPE takes a control-oriented approach and seeks to structure transactions to ensure the ability to influence critical decisions for a portfolio company, particularly as it relates to specific value-added initiatives. A key element of their transaction negotiation with partners and management centers on contractual rights and board representation that facilitate input into key decisions such as management changes, expansion plans, acquisitions, budgets, debt and equity financings and new initiatives. MLGP implements value creation initiatives such as organic growth alternatives, acquisitions and other strategic initiatives, business rationalization and operational improvements and capital structure improvements in partnership with portfolio company management. They are actively involved in significant portfolio company decisions, including those relating to potential acquisitions, expansion plans, debt and equity financings, changes in senior management and new business initiatives. | Finance |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Medical Forensic Specialists, Inc.
American Medical Forensic Specialists, Inc. Hospital/Nursing ManagementHealth Services Provides medical services | Health Services |
Tecmotiv USA, Inc.
Tecmotiv USA, Inc. Motor VehiclesConsumer Durables Provides maintenance, repair, overhaul and upgrade services and related components for military vehicle platforms | Consumer Durables |
Sentire Medical Systems, Inc.
Sentire Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops revolutionary monitoring system | Electronic Technology |
RedNest Partners, LLC
RedNest Partners, LLC Investment ManagersFinance RedNest Partners invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for growth stage capital requirements. | Finance |
Nanocan Therapeutics Corp.
Nanocan Therapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a bio technology company | Commercial Services |
